A Study of GQ1005 in Subjects With HER2-Expressing Advanced Solid Tumors

Conditions: HER2 Expressing or Mutated Advanced Malignant Solid Tumors Interventions: Drug: GQ1005 Sponsors: GeneQuantum Healthcare (Suzhou) Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials